Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

siRNA based drug design, quality, delivery and clinical translation
Md Abdus Subhan, Torchilin Vp
Nanomedicine Nanotechnology Biology and Medicine (2020) Vol. 29, pp. 102239-102239
Closed Access | Times Cited: 127

Showing 1-25 of 127 citing articles:

New approaches and procedures for cancer treatment: Current perspectives
Dejene Tolossa Debela, Seke GY Muzazu, Kidist Digamo Heraro, et al.
SAGE Open Medicine (2021) Vol. 9
Open Access | Times Cited: 945
Exosome engineering: Current progress in cargo loading and targeted delivery
Shengyang Fu, Yi Wang, Xiaohuan Xia, et al.
NanoImpact (2020) Vol. 20, pp. 100261-100261
Open Access | Times Cited: 330
siRNA: Mechanism of action, challenges, and therapeutic approaches
Walhan Alshaer, Hadil Zureigat, Arwa Al Karaki, et al.
European Journal of Pharmacology (2021) Vol. 905, pp. 174178-174178
Closed Access | Times Cited: 279
Overcoming Barriers for siRNA Therapeutics: From Bench to Bedside
Muhammad Imran Sajid, Muhammad Moazzam, Shun Kato, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 10, pp. 294-294
Open Access | Times Cited: 185
Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome
Makhloufi Zoulikha, Qingqing Xiao, George Frimpong Boafo, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 600-620
Open Access | Times Cited: 178
Cancer treatment therapies: traditional to modern approaches to combat cancers
Rasanpreet Kaur, Alok Bhardwaj, Saurabh Gupta
Molecular Biology Reports (2023) Vol. 50, Iss. 11, pp. 9663-9676
Closed Access | Times Cited: 123
Small interfering RNA: Discovery, pharmacology and clinical development—An introductory review
Priyanga Ranasinghe, Melisande Addison, James W. Dear, et al.
British Journal of Pharmacology (2022) Vol. 180, Iss. 21, pp. 2697-2720
Open Access | Times Cited: 73
Small interfering RNA (siRNA)-based therapeutic applications against viruses: principles, potential, and challenges
Hara Kang, Yun Ji Ga, Soo Hyun Kim, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 54
A Comprehensive Review of Small Interfering RNAs (siRNAs): Mechanism, Therapeutic Targets, and Delivery Strategies for Cancer Therapy
Jiaying Zhang, Bo Chen, Chunyuan Gan, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 7605-7635
Open Access | Times Cited: 47
Shape memory materials and 4D printing in pharmaceutics
Alice Melocchi, Marco Uboldi, Matteo Cerea, et al.
Advanced Drug Delivery Reviews (2021) Vol. 173, pp. 216-237
Open Access | Times Cited: 91
Exosomes as Drug Delivery Systems: Endogenous Nanovehicles for Treatment of Systemic Lupus Erythematosus
Ana Ortega, Olga Martínez-Arroyo, María José Forner, et al.
Pharmaceutics (2020) Vol. 13, Iss. 1, pp. 3-3
Open Access | Times Cited: 73
Combination Therapy of Breast Cancer by Codelivery of Doxorubicin and Survivin siRNA Using Polyethylenimine Modified Silk Fibroin Nanoparticles
Parisa Norouzi, Hamidreza Motasadizadeh, Fatemeh Atyabi, et al.
ACS Biomaterials Science & Engineering (2021) Vol. 7, Iss. 3, pp. 1074-1087
Closed Access | Times Cited: 57
Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases
Meihua Luo, Leo Kit Cheung Lee, Bo Peng, et al.
Advanced Science (2022) Vol. 9, Iss. 26
Open Access | Times Cited: 43
siRNA therapeutics and its challenges: Recent advances in effective delivery for cancer therapy
Arpita Paul, Anuraag Muralidharan, Avirup Biswas, et al.
OpenNano (2022) Vol. 7, pp. 100063-100063
Open Access | Times Cited: 40
Targeted Treatment against Lipoprotein (a): The Coming Breakthrough in Lipid Lowering Therapy
Bożena Sosnowska, Stanisław Surma, Maciej Banach
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1573-1573
Open Access | Times Cited: 40
Advances in siRNA delivery approaches in cancer therapy: challenges and opportunities
Houman Isazadeh, Farshid Oruji, Shima Shabani, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 11, pp. 9529-9543
Closed Access | Times Cited: 32
An Overview of the Stability and Delivery Challenges of Commercial Nucleic Acid Therapeutics
Rahul G Ingle, Wei‐Jie Fang
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1158-1158
Open Access | Times Cited: 31
Edible and cation-free kiwi fruit derived vesicles mediated EGFR-targeted siRNA delivery to inhibit multidrug resistant lung cancer
Haoying Huang, Xiaohan Yi, Qingyun Wei, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 27
The emerging potential of siRNA nanotherapeutics in treatment of arthritis
Anjali Kumari, Amanpreet Kaur, Geeta Aggarwal
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 5, pp. 100845-100845
Open Access | Times Cited: 23
Principle, application and challenges of development siRNA-based therapeutics against bacterial and viral infections: a comprehensive review
Hamid Motamedi, Marzie Mahdizade Ari, Amirhoushang Alvandi, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 8
Non-viral nanoparticles for RNA interference: Principles of design and practical guidelines
Zehua Liu, Shiqi Wang, Christos Tapeinos, et al.
Advanced Drug Delivery Reviews (2021) Vol. 174, pp. 576-612
Open Access | Times Cited: 55
Advances in the Design of (Nano)Formulations for Delivery of Antisense Oligonucleotides and Small Interfering RNA: Focus on the Central Nervous System
Monique Culturato Padilha Mendonça, Ayse Kont, María R. Aburto, et al.
Molecular Pharmaceutics (2021) Vol. 18, Iss. 4, pp. 1491-1506
Open Access | Times Cited: 47
siRNA Therapeutics for the Therapy of COVID-19 and Other Coronaviruses
Muhammad Imran Sajid, Muhammad Moazzam, Yeseom Cho, et al.
Molecular Pharmaceutics (2021) Vol. 18, Iss. 6, pp. 2105-2121
Open Access | Times Cited: 43
Nanoparticle‐mediated siRNA delivery systems for cancer therapy
Han Gao, Ruoyu Cheng, Hélder A. Santos
View (2021) Vol. 2, Iss. 3
Open Access | Times Cited: 42
Biomimetic GBM-targeted drug delivery system boosting ferroptosis for immunotherapy of orthotopic drug-resistant GBM
Bao Liu, Qifeng Ji, Ying Cheng, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top